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Though the lymphatic system is involved in many essential bodily functions, little 
is known about its role in the progression of lymphatic diseases like lymphedema. 
Recently, inflammation has been implicated as the primary mediator of lymphatic 
pathologies, due to its ability to decrease lymphatic function and induce a mal-adaptive 
remodeling response (Aldrich & Sevick-Muraca, 2013). One of the failure modes that 
inflammation is hypothesized to influence is by increasing the permeability of the 
lymphatic vasculature (Scallan & Huxley, 2010). A minimally-invasive method of 
quantifying lymphatic vessel permeability was designed using near-infrared imaging, a 
fluorescent tracer, and applied pressure. The method partially occluded the lymphatic 
collecting vessels and was tested using IFN-γ as a positive control. The average apparent 
permeability for the control group was determined to be somewhat similar to a previous 
in vivo study of isolated vessels but had a wide range of values overall (Scallan & 
Huxley, 2010). Comparison of the IFN-γ treated group to the control group revealed no 
significant difference and therefore inconclusive results as to the accuracy of the method. 
Future work will include testing different positive controls to verify the method followed 
by application of the method on diet-induced obese mice for determination of the changes 
to vessel permeability as compared to the control group to understand possible causes 








The lymphatic system is a network of vessels, nodes, and accessory organs that serves 
many essential biological functions. Most notably the lymphatic system is responsible for 
immune cell trafficking, absorbing and transporting lipids from the digestive system, and 
restoring fluids extravagated from the circulatory system. Despite these essential functions, little 
is known about the role of the lymphatics in the progression of a variety of diseases. Previous 
studies have identified changes in the lymphatic vasculature characteristic of lymphedema to 
include dermal backflow, dilated lymphatic vessels, and decreased effective pumping pressure 
(Unno et al., 2007; Nelson et al., 2014). However, the causes of the changes to the lymphatic 
system that result in dysfunction still need to be investigated before a cure can be developed. A 
novel technique being developed is near-infrared (NIR) imaging, which uses a fluorescent dye to 
image the lymphatic vessel in real time (Rasmussen et al., 2009). This technique has the 
potential to serve as a new diagnostic tool for lymphatic diseases like lymphedema; it could 
significantly improve the lives of the individuals affected by providing early detection of the 
abnormalities in the lymphatic system and facilitating immediate treatment.  
Using fluorescence imaging, previous research has been conducted to assess the 
permeability of the lymphatic vessel in vivo (Scallan & Huxley, 2010). However, changes to 
lymphatic permeability that occur due to inflammation have yet to be determined using a 
minimally invasive in vivo method. The current experiment expands on previous studies by 
developing a minimally invasive method of quantifying permeability in vivo in order to assess 
the changes that occur due to inflammation as seen in lymphedema patients. The results of this 
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study contribute a methodology to a better understanding of the lymphatic system, which could 






The lymphatic system has become increasingly popular in current studies due to the 
growing prevalence of lymphatic disease in the population. One of these diseases is secondary 
lymphedema, which is an acquired lymphatic disease characterized by swelling of the affected 
limb and fluid stagnation that can occur as a result of breast cancer treatment in addition to other 
causes (Morrell et al., 2005). Currently, lymphedema has no cure, and the success of the 
treatment options varies depending on the individual and stage at which the disease is detected 
(Cheifetz et al., 2010). Studies have estimated that the incidence of breast cancer-related 
lymphedema is approximately 12%, but the various detection methods currently available such 
as circumferential methods and self-reporting have led to many undetected cases and false 
diagnoses (Hayes et al., 2008; Thomas-Maclean et al., 2008). These techniques also are 
ineffective in the early stages of the disease, so magnetic resonance imaging (MRI), computed 
tomography (CT), and lymphoscintigraphy have been utilized for improved early diagnosis and 
thus more effective treatment of the disease due to the ability to assess lymphatic function and 
dysfunction (Mihara et al., 2012).  
A novel technique being developed is near-infrared (NIR) imaging, which is a minimally 
invasive technique that uses a fluorescent dye optimized for uptake by the lymphatics to image 
the lymphatic system in real time (Rasmussen et al., 2009). When this technique was compared 
to the other imaging methods currently in use, Mihara and colleagues found that NIR imaging 
was the superior method in terms of sensitivity to determine changes in the lymphatic system due 
to the onset of lymphatic disease (Mihara et al., 2012). Currently, the fluorescent dye used to 
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image the lymphatic vessels is indocyanine green (ICG), since it has already been FDA approved 
for use in other diagnostic techniques. However, previous studies have shown that ICG adversely 
affects lymphatic function (Weiler & Dixon, 2013). As a result, the dye LI-COR IRDye 800CW 
NHS ester was conjugated to a PEG amine by a modified protocol described by Proulx and 
colleagues for studies involving the quantification of lymphatic properties with NIR imaging to 
avoid confounding the results with the effect of the dye on lymphatic function (Proulx et al., 
2013).  
In order to better understand how lymphedema occurs, a more detailed understanding is 
needed of the changes in the lymphatic vasculature that result in dysfunction. Previous studies 
have found that obesity can increase the risk of the development of lymphedema after breast 
cancer treatment (Treves, 1957). In addition, obesity alone was found to be a potential cause of 
the development of lymphedema through the comparison of two groups of individuals with 
varying body mass indexes in a study conducted by Greene and colleagues (Greene et al., 2015). 
The correlation between obesity and lymphatic disease could be due to the chronic inflammation 
present in obese individuals. Our lab has demonstrated that nitric oxide, which is released during 
inflammation, causes impaired function of the affected lymphatic vessels seen through reduced 
fluid transport (Weiler et al., 2012). Inflammation has also been implicated to cause increased 
vessel permeability, which could contribute to the development of lymphatic dysfunction 
(Scallan & Huxley, 2010). However, studies have yet to develop minimally invasive methods to 
analyze the effect of inflammation on lymphatic vessel permeability due to the previous 
difficulty of imaging fluid transport through the lymphatic vessel in real time.  
This study aims to use NIR imaging in combination with the LI-COR IRDye 800CW 
NHS ester to develop a minimally invasive technique to quantify lymphatic vessel permeability 
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in vivo by combining and modifying previously described techniques of dye infusion at constant 
pressure with permeability calculations (Swartz & Boucher, 1999; Scallan & Huxley, 2010). The 
method will then be utilized for future studies in models of diet-induced obesity to observe the 
changes that occur to lymphatic vessel permeability as a result of chronic inflammation induced 
by obesity. C57BL/6 mice have been chosen as the obesity model due to previous studies 
showing their susceptibility to obesity while on a high-fat diet, which resulted in up-regulation of 
pro-inflammatory cytokines in adipose tissues (Montgomery et al., 2013). Comparison of the 
lymphatic vessel permeability in obese C57BL/6 mice to that of BALB/c mice, which have been 
shown to have some resistance to obesity, will reveal the changes to the lymphatic vasculature 
caused by chronic inflammation that result in lymphatic dysfunction (Montgomery et al., 2013; 
Savetsky et al., 2014). By having a better understanding of the effects of chronic inflammation 
on the lymphatic system, the findings of this study will contribute towards the long-term goal of 






MATERIALS AND METHODS 
 
Synthesis of PEG-IRDye 
 Methoxypoly(ethylene glycol) (PEG) amine (13kDa, 15nmol) was dissolved in 
anhydrous DMSO with heat. The PEG molecules were labeled with LI-COR IRDye 800CW 
NHS ester (LI-COR Biosciences, Lincoln, NE) predissolved in anhydrous DMSO (8.57nmol) at 
room temperature for 48 hours. The crude dye solution was purified for 48 hours using Slide-A-
LyzerTM Dialysis Cassettes (Thermo Fisher Scientific, Rockford, IL) then lyophilyzed overnight. 
The freeze-dried product stored at -20˚C was reconstituted in double-distilled water (40µL) prior 
to use. 
  
Fluorescence Image Capture via Near-Infrared Imaging 
  Lymphatic vessel permeability was quantified in the tail of six-month-old female 
BALB/c mice (Charles River Laboratories, Wilmington, MA) in accordance with procedures 
approved by the Georgia Institute of Technology IACUC Review Board. Mice were anesthetized 
with 5% isoflurane for about 10 minutes. After the anesthetic had taken effect, mice were kept on 
about 1.5% isoflurane for the rest of the experiment and positioned under the camera either on its 
stomach or on its side so that the field of view was 2 cm from the base of the tail. A pressure cuff 
connected to a pressure cuff controller and a custom-made LabView program previously 
developed in the lab was positioned proximal to the field of view with only the edge of the cuff 
visible (Nelson et al., 2014). The magnification on the camera was set to 1.25X with a camera 
exposure time of 50ms, and the percent light transmittance was adjusted to 8% using neutral 
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(Scallan & Huxley, 2010) 
density filters. The PEG-IRDye (0.25mg/mL, 10µL) was injected intradermally into the tip of the 
mouse tail. Image acquisition of the lymphatic vessels using a custom NIR lymphatic imaging 
device and LabView program developed previously by the lab (Weiler et al., 2012) began just 
before injection at a rate of 1fps and lasted for 15 minutes. Once fluorescence was seen in the 
lymphatic collecting vessels, the pressure cuff was applied at 60mmHg and held constant until 
the end of the image acquisition to partially occlude the lymphatic vessels and encourage fluid 
leakage from the vessels.  
 
Image Processing 
 Fluorescence measurements were taken in the region of interest (ROI) to include either 
the region between the two lymphatic vessels or around one lymphatic vessel and surrounding 
tissue in the mouse tail using ImageJ software to quantify the fluorescence intensities (NIH, 
Bethesda, MD). The fluorescence intensity was plotted over time, and the change in fluorescence 
intensity over time was determined using a linear regression. 
 
Calculation of Apparent Vessel Permeability 
 Calculation of the apparent vessel permeability (Ps, cm s-1) was done using an equation 
derived by Scallan and colleagues that linked the change in fluorescence intensity over time 
(dIf/dt) in the region of interest after application of the pressure cuff at 60mmHg to the volume-
to-surface area ratio (D/4). The diameter of the lymphatic collecting vessel was estimated to be 
25µm. The intensity values were normalized using the initial fluorescence intensity value (Io) 










Treatment of IFN-γ 
Three hours prior to imaging, mice were anesthetized with 5% isoflurane for about 10 
minutes. After the anesthetic had taken effect, the mice were maintained on about 1.5% 
isoflurane for injection of IFN-γ in sterile PBS (1µg/mouse) at the tip of the tail intradermally 
until after treatment. Image capture was performed identically to the control group with the ROI 







The NIR imaging conditions were optimized to prevent photobleaching of the fluorescent 
dye. NIR imaging of the region of interest over time was used to track the movement of the 
injected tracer through the lymphatic collecting vessel and surrounding interstitium. The change 
in fluorescence intensity over time was measured between the two lymphatic vessels (Figure 1) 
and around one vessel for the control group (Figure 2). The dye was seen to leak into the 
surrounding tissue from the collecting vessel over time.  
 
Figure 1. Images over time of a mouse tail distal to an occlusion cuff at a pressure of 60mmHg after a 13kDa 




Figure 2. Images of the side of the mouse tail over time after injection of the fluorophore to show the accumulation 
of fluorescence in the region of interest (red box) after partial vessel occlusion. 
 
The fluorescence intensity in the ROI was quantified and plotted over time to determine 
the overall change in fluorescence intensity (Figures 3-4).  
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Figure 3. Quantification of the fluorescence intensity over time in the region of interest between the two collecting 
lymphatic vessels of the mouse tail. Pressure (60 mmHg) to occlude the lymphatic vessels was applied to the tail 
after 110 seconds. 
 
 
Figure 4. Plot of the fluorescence intensity when the ROI was around one lymphatic vessel as a function of time 
showing the gradual increase in fluorescence due to dye accumulation in the interstitial tissue around the lymphatic 
collecting vessel after pressure (60 mmHg) was applied after 80 seconds. 
  
Apparent permeability was calculated using the equation derived by Scallan and 
colleagues and determined to be 8.08 x 10-6 ± 9.71 x 10-6 cm s-1 when the ROI was between the 
two lymphatic vessels and 6.09 x 10-6 ± 6.08 x 10-6 cm s-1 when the ROI was around one 
lymphatic vessel (Scallan & Huxley, 2010). 
To determine the effect of induced inflammation on lymphatic vessel permeability, mice 
were treated locally with IFN-γ prior to imaging. The change in fluorescence intensity over time 





















Figure 5. Plot of the fluorescence intensity over time in the ROI between the two lymphatic vessels with and without 
treatment of IFN-γ. Pressure (60 mmHg) to partially occlude the lymphatic vessels was applied after fluorescence 
was seen in the ROI. 
 
The apparent permeability of the IFN-γ treated group was compared to the control and 
found to be a nonsignificant difference after evaluation by a Student’s T-Test to obtain a p-value 
of 0.135 (Figure 6). 
 
Figure 6. Comparison of the average apparent vessel permeability for the control and IFN-γ treated groups with 
































Imaging of the fluorescent tracer through the lymphatic collecting vessel showed an 
initial increase in fluorescence intensity as the dye entered the ROI followed by a gradual 
increase correlating to the dye accumulated in the vessel and surrounding tissue for most trials, 
as shown in Figures 1-4. Secondary collecting vessels in parallel were seen in some animals to 
assist in fluid transport through the tail. Overall, partial occlusion of the lymphatic collecting 
vessels at 60 mmHg was sufficient to promote dye leakage through the vessel walls into the 
surrounding tissue. The calculated average apparent vessel permeability in the control group 
using both imaging methods was somewhat similar to a previous in vivo study of isolated vessels 
but had a wide range of values overall, shown by the large standard deviation (Scallan & Huxley, 
2010).  
The increase in fluorescence intensity in the lymphatic vessels of the IFN-γ treated group 
followed a similar trend to the control group. The initial increase in the fluorescence intensity in 
the ROI following injection of the tracer was more gradual than that of the control group for 
most trials. The average apparent permeability in the control group was compared to that of the 
IFN-γ treated group to verify the imaging method for quantification of vessel permeability, since 
IFN-γ was thought to increase the permeability of the lymphatic vessels. The apparent vessel 
permeability in the IFN-γ treated group was opposite of what was expected and was smaller than 
the calculated average apparent permeability of the control group. However, the difference in the 
apparent permeabilities was not significant as shown by the p-value of 0.135, suggesting that 
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IFN-γ did not increase the permeability of the lymphatic vessels or that the designed method was 




CONCLUSION AND FUTURE WORK 
 
A minimally-invasive method for quantification of lymphatic vessel permeability in vivo 
was designed for determination of the role that vessel permeability plays in the progression of 
lymphedema. This technique was then tested using the positive control IFN-γ to verify its 
accuracy. There was a non-significant difference between the control group and IFN-γ treated 
groups and the lower calculated average Ps of the IFN-γ treated group than the control group, 
which questions the accuracy of the method or the validity of the positive control. Future work 
will include testing different positive controls known to increase lymphatic vessel permeability 
for verification of the method for quantification of vessel permeability. Once the method has 
been established, the apparent lymphatic vessel permeability in models of diet-induced obesity 
will be calculated to compare to the control for determination of any changes to vessel 
permeability, since obesity is a major risk factor for the development of lymphedema and can 
worsen the symptoms (Treves, 1957; Greene et al., 2015). The results of this study will 
contribute to the knowledge about the progression of lymphedema and to the development of 
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